 |
 |
 |
 |
 |
Treatment Name: |
 |
Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma |
 |
 |
 |
 |
Phase: |
 |
Phase 2 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
504 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
50: Requires considerable assistance and frequent medical care |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
05/01/2007 |
 |
 |
 |
 |
Tumor Types: |
 |
Anaplastic Astrocytoma Brainstem Glioma Glioblastoma Multiforme Metastatic Brain Tumor Mixed Glioma Oligodendroglioma High Grade Oligodendroglioma Low Grade Optic Glioma Pineal Gland Tumor |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy |
 |
 |
 |
 |
Contact: |
 |
Dr.Edward Neuwelt M.D. Professor Oregon Health Sciences University 3181 SW Sam Jackson Park Rd L603 Portland, OR 97239 USA Phone: (503)494-5626 Fax: (503)494-5627 E-mail: neuwelte@ohsu.edu Website: www.ohsu.edu/bbb |
 |
 |